Journal
CELL
Volume 133, Issue 5, Pages 801-812Publisher
CELL PRESS
DOI: 10.1016/j.cell.2008.04.029
Keywords
-
Categories
Funding
- MRC [G0500367] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BBS/B/14426] Funding Source: researchfish
- Medical Research Council [G0500367] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council [BBS/B/14426] Funding Source: Medline
- Medical Research Council [G0500367] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
The XPD helicase (Rad3 in Saccharomyces cerevisiae) is a component of transcription factor IIH (TFIIH), which functions in transcription initiation and Nucleotide Excision Repair in eukaryotes, catalyzing DNA duplex opening localized to the transcription start site or site of DNA damage, respectively. XPD has a 50 to 30 polarity and the helicase activity is dependent on an iron-sulfur cluster binding domain, a feature that is conserved in related helicases such as FancJ. The xpd gene is the target of mutation in patients with xeroderma pigmentosum, trichothiodystrophy, and Cockayne's syndrome, characterized by a wide spectrum of symptoms ranging from cancer susceptibility to neurological and developmental defects. The 2.25 angstrom crystal structure of XPD from the crenarchaeon Sulfolobus tokodaii, presented here together with detailed biochemical analyses, allows a molecular understanding of the structural basis for helicase activity and explains the phenotypes of xpd mutations in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available